TY - JOUR
T1 - Combined versus sequential pars plana vitrectomy and phacoemulsification for macular hole and epiretinal membrane
T2 - a systematic review and meta-analysis
AU - Daud, Fowad
AU - Daud, Kashif
AU - Popovic, Marko M.
AU - Yeung, Shanna
AU - You, Yuyi
AU - Pimentel, Miguel Cruz
AU - Yan, Peng
PY - 2023/8
Y1 - 2023/8
N2 - Topic: Comparing the efficacy and safety between combined and sequential pars plana vitrectomy and phacoemulsification for macular hole (MH) and epiretinal membrane (ERM). Clinical relevance: The standard of care for MH and ERM is vitrectomy, which increases the risk of developing cataract. Combined phacovitrectomy eliminates the need for a second surgery. Methods: Ovid MEDLINE, EMBASE, and Cochrane CENTRAL were searched in May 2022 for all articles comparing combined versus sequential phacovitrectomy for MH and ERM. The primary outcome was mean best-corrected visual acuity (BCVA) at 12 months follow-up. Meta-analysis was conducted using a random effects model. Risk of bias (RoB) was assessed using the Cochrane RoB 2 tool for randomized controlled trials (RCTs) and Risk of Bias in Nonrandomized Studies of Interventions tool for observational studies (PROSPERO, registration number, CRD42021257452). Results: Of the 6470 studies found, 2 RCTs and 8 nonrandomized retrospective comparative studies were identified. Total eyes for combined and sequential groups were 435 and 420, respectively. Meta-analysis suggested no significant difference between combined and sequential surgery for 12-month BCVA (combined = 0.38 logarithm of the minimum angle of resolution [logMAR]; sequential = 0.36 logMAR; mean difference = + 0.02 logMAR; 95% confidence interval = −0.04 to 0.08; P = 0.51; I 2 = 0%; n = 4 studies, 398 participants), as well as absolute refractive error (P = 0.76; I 2 = 97%; n = 4 studies, 289 participants), risk of myopia (P = 0.15; I 2 = 66%; n = 2 studies, 148 participants), MH nonclosure (P = 0.57; I 2 = 48%; n = 4 studies, 321 participants), cystoid macular edema (P = 0.15; I 2 = 0%; n = 6 studies, 526 participants), high-intraocular pressure (P = 0.09; I 2 = 0%; n = 2 studies, 161 participants), posterior capsule opacification (P = 0.46; I 2 = 0%; n = 2 studies, 161 participants), posterior capsule rupture (P = 0.41; I 2 = 0%; n = 5 studies, 455 participants), and retinal detachment (P = 0.67; I 2 = 0%; n = 6 studies, 545 participants). Conclusion: No significant difference was detected between combined and sequential surgeries for visual outcomes, refractive outcomes, or complications. Given that most studies were retrospective and contained a high RoB, future high-quality RCTs are warranted. Financial Disclosure(s): Proprietary or commercial disclosure may be found after the references.
AB - Topic: Comparing the efficacy and safety between combined and sequential pars plana vitrectomy and phacoemulsification for macular hole (MH) and epiretinal membrane (ERM). Clinical relevance: The standard of care for MH and ERM is vitrectomy, which increases the risk of developing cataract. Combined phacovitrectomy eliminates the need for a second surgery. Methods: Ovid MEDLINE, EMBASE, and Cochrane CENTRAL were searched in May 2022 for all articles comparing combined versus sequential phacovitrectomy for MH and ERM. The primary outcome was mean best-corrected visual acuity (BCVA) at 12 months follow-up. Meta-analysis was conducted using a random effects model. Risk of bias (RoB) was assessed using the Cochrane RoB 2 tool for randomized controlled trials (RCTs) and Risk of Bias in Nonrandomized Studies of Interventions tool for observational studies (PROSPERO, registration number, CRD42021257452). Results: Of the 6470 studies found, 2 RCTs and 8 nonrandomized retrospective comparative studies were identified. Total eyes for combined and sequential groups were 435 and 420, respectively. Meta-analysis suggested no significant difference between combined and sequential surgery for 12-month BCVA (combined = 0.38 logarithm of the minimum angle of resolution [logMAR]; sequential = 0.36 logMAR; mean difference = + 0.02 logMAR; 95% confidence interval = −0.04 to 0.08; P = 0.51; I 2 = 0%; n = 4 studies, 398 participants), as well as absolute refractive error (P = 0.76; I 2 = 97%; n = 4 studies, 289 participants), risk of myopia (P = 0.15; I 2 = 66%; n = 2 studies, 148 participants), MH nonclosure (P = 0.57; I 2 = 48%; n = 4 studies, 321 participants), cystoid macular edema (P = 0.15; I 2 = 0%; n = 6 studies, 526 participants), high-intraocular pressure (P = 0.09; I 2 = 0%; n = 2 studies, 161 participants), posterior capsule opacification (P = 0.46; I 2 = 0%; n = 2 studies, 161 participants), posterior capsule rupture (P = 0.41; I 2 = 0%; n = 5 studies, 455 participants), and retinal detachment (P = 0.67; I 2 = 0%; n = 6 studies, 545 participants). Conclusion: No significant difference was detected between combined and sequential surgeries for visual outcomes, refractive outcomes, or complications. Given that most studies were retrospective and contained a high RoB, future high-quality RCTs are warranted. Financial Disclosure(s): Proprietary or commercial disclosure may be found after the references.
KW - Cataract
KW - Epiretinal membrane
KW - Macular hole
KW - Phacovitrectomy
KW - Retina
UR - http://www.scopus.com/inward/record.url?scp=85159901474&partnerID=8YFLogxK
U2 - 10.1016/j.oret.2023.03.017
DO - 10.1016/j.oret.2023.03.017
M3 - Review article
C2 - 37030392
SN - 2468-7219
VL - 7
SP - 721
EP - 731
JO - Ophthalmology Retina
JF - Ophthalmology Retina
IS - 8
ER -